Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00235885
Status:
COMPLETED
Last Update Posted:
2007-08-29
First Post:
2005-10-07
Brief Title:
Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis PsA
Sponsor:
Abbott
Organization:
Abbott
Study Overview
Official Title:
Safety and Efficacy of Adalimumab in Patients With Active Psoriatic Arthritis PsA - An Open-Label Multinational Study to Evaluate the Response to Every-Other Week Adalimumab When Added to Insufficient Standard Therapy Including Patients Who Failed Prior Treatment With Other TNF-Inhibitors STEREO
Status:
COMPLETED
Status Verified Date:
2007-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
STEREO
Brief Summary:
The purpose of the study is to assess the safety and clinical efficacy of adalimumab in active psoriatic arthritis PsA subjects when adalimumab is added to insufficient standard therapy including patients that have failed other TNF therapies
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| EudraCT 2005001185-14 | None | None | None |